OK Bulletin 2024-11
Bulletin No. 2024-11: Use of Artificial Intelligence Systems in Insurance
Page 1 of 11
BULLETIN NO. 2024-11
TO:
All Insurers Licensed To Do Business In Oklahoma (“Insurers”)
RE:
Use of Artificial Intelligence Systems in Insurance
From:
Glen Mulready, Insurance Commissioner
DATE:
November 14, 2024
The Oklahoma Insurance Department issues this bulletin to remind all Insurers that hold
certificates of authority to do business in the state that decisions or actions impacting consumers
that are made or supported by advanced analytical and computational technologies, including
Artificial Intelligence (AI) Systems (as defined below), must comply with all applicable insurance
laws and regulations. This includes those laws that address unfair trade practices and unfair
discrimination. This bulletin sets forth the Department’s expectations as to how Insurers will
govern the development/acquisition and use of certain AI technologies, including the AI Systems
described herein. This bulletin also advises Insurers of the type of information and documentation
that the Department may request during an investigation or examination of any Insurer regarding
its use of such technologies and AI Systems.
SECTION 1: INTRODUCTION, BACKGROUND, AND LEGISLATIVE AUTHORITY
Background
AI is transforming the insurance industry. AI techniques are deployed across all stages of
the insurance life cycle, including product development, marketing, sales and distribution,
underwriting and pricing, policy servicing, claim management, and fraud detection.
AI may facilitate the development of innovative products, improve consumer interface
and service, simplify, and automate processes, and promote efficiency and accuracy. However,
AI, including AI Systems, can present unique risks to consumers, including the potential for
inaccuracy, unfair discrimination, data vulnerability, and lack of transparency and explainability.
Insurers should take actions to minimize these risks.
The Department encourages the development and use of innovation and AI Systems that
contribute to safe and stable insurance markets. However, the Department expects that decisions
made, and actions taken by Insurers using AI Systems will comply with all applicable federal and
state laws and regulations.
Page 2 of 11
The Department recognizes the Principles of Artificial Intelligence that the NAIC adopted
in 2020 as an appropriate source of guidance for Insurers as they develop and use AI systems.
Those principles emphasize the importance of the fairness and ethical use of AI; accountability;
compliance with state laws and regulations; transparency; and a safe, secure, fair, and robust
system. These fundamental principles should guide Insurers in their development and use of AI
Systems and underlie the expectations set forth in this bulletin.
Legislative Authority
The regulatory expectations and oversight considerations set forth in Section 3 and
Section 4 of this bulletin rely on the following laws and regulations:
•
Unfair Trade Practices Model Act (#880): The Unfair Practices and Frauds, 36
O.S. §§ 1201, et seq. (UTPA), regulates trade practices in insurance by: 1) defining
practices that constitute unfair methods of competition or unfair or deceptive acts
and practices; and 2) prohibiting the trade practices so defined or determined.
•
Unfair Claims Settlement Practices Model Act (#900): The Unfair Claims
Settlement Practices Act, 36 O.S. §§ 1250.1, et seq. (UCSPA), sets forth standards
for the investigation and disposition of claims arising under policies or certificates
of insurance issued to residents of Oklahoma.
Actions taken by Insurers in the state must not violate the UTPA or the UCSPA, regardless
of the methods the Insurer used to determine or support its actions. As discussed below, Insurers
are expected to adopt practices, including governance frameworks and risk management
protocols, that are designed to ensure that the use of AI Systems does not result in: 1) unfair trade
practices, as defined in 36 O.S. § 1204; or 2) unfair claims settlement practices, as defined in 36
O.S. § 1250.5.
•
Corporate Governance Annual Disclosure Model Act (#305): The Corporate
Governance Annual Disclosure Act, 36 O.S. §§ 1534, et seq. (CGAD), requires
Insurers to report on governance practices and to provide a summary of the
Insurer’s corporate governance structure, policies, and practices. The content,
form, and filing requirements for CGAD information are set forth in the Corporate
Governance Annual Disclosure Model Regulation (#306), OAC 365:25-7-90, et
sec. (CGAD-R).
The requirements of CGAD and CGAD-R apply to elements of the Insurer’s corporate
governance framework that address the Insurer’s use of AI Systems to support actions and
decisions that impact consumers.
•
Property and Casualty Model Rating Law (#1780): The Property and Casualty
Competitive Loss Cost Rating Act, 36 O.S. §§ 981–998, requires that
property/casualty (P/C) insurance rates not be excessive, inadequate, or unfairly
discriminatory when the Oklahoma Insurance Commissioner finds the Oklahoma
insurance market is no longer a competitive market. Oklahoma law requires that
Page 3 of 11
rates in a competitive market shall not be inadequate or unfairly discriminatory.
The requirements here apply regardless of the methodology that the Insurer used to
develop rates, rating rules, and rating plans subject to those provisions. That means that an Insurer
is responsible for assuring that rates, rating rules, and rating plans that are developed using AI
techniques and Predictive Models that rely on data and Machine Learning do not result in
insurance rates that do not comply with Oklahoma law with respect to all forms of property and
casualty insurance—excluding those listed in 36 O.S. § 983(1) through (5), and any combination
of any of the foregoing, as required under Oklahoma law.
•
Market Conduct Law: The Market Conduct Law, 36 O.S. §§ 309.1–309.7 &
311.4, establishes the framework pursuant to which the Department conducts
market conduct actions. These are comprised of the full range of activities that the
Department may initiate to assess and address the market practices of Insurers,
beginning with market analysis and extending to targeted examinations. Market
conduct actions are separate from, but may result from, individual complaints
made by consumers asserting illegal practices by Insurers.
An Insurer’s conduct in the state, including its use of AI Systems to make or support
actions and decisions that impact consumers, is subject to investigation, including market conduct
actions. Section 4 of this bulletin provides guidance on the kinds of information and documents
that the Department may request in the context of an AI-focused investigation, including a market
conduct action.
SECTION 2: DEFINITIONS
For the purposes of this bulletin the following terms are defined:
“Adverse Consumer Outcome” refers to a decision by an Insurer that is subject to insurance
regulatory standards enforced by the Department that adversely impacts the consumer in a manner
that violates those standards.
“Algorithm” means a clearly specified mathematical process for computation; a set of rules that,
if followed, will give a prescribed result.
“AI System” is a machine-based system that can, for a given set of objectives, generate outputs
such as predictions, recommendations, content (such as text, images, videos, or sounds), or other
output influencing decisions made in real or virtual environments. AI Systems are designed to
operate with varying levels of autonomy.
“Artificial Intelligence (AI)” refers to a branch of computer science that uses data processing
systems that perform functions normally associated with human intelligence, such as reasoning,
learning, and self-improvement, or the capability of a device to perform functions that are normally
associated with human intelligence such as reasoning, learning, and self-improvement. This
definition considers machine learning to be a subset of artificial intelligence.
Page 4 of 11
“Degree of Potential Harm to Consumers” refers to the severity of adverse economic impact
that a consumer might experience as a result of an Adverse Consumer Outcome.
“Generative Artificial Intelligence (Generative AI)” refers to a class of AI Systems that
generate content in the form of data, text, images, sounds, or video, that is similar to, but not a
direct copy of, pre-existing data or content.
“Machine Learning (ML)” Refers to a field within artificial intelligence that focuses on the
ability of computers to learn from provided data without being explicitly programmed.
“Model Drift” refers to the decay of a model’s performance over time arising from underlying
changes such as the definitions, distributions, and/or statistical properties between the data used
to train the model and the data on which it is deployed.
“Predictive Model” refers to the mining of historic data using algorithms and/or machine
learning to identify patterns and predict outcomes that can be used to make or support the making
of decisions.
“Third Party” for purposes of this bulletin means an organization other than the Insurer that
provides services, data, or other resources related to AI.
SECTION 3: REGULATORY GUIDANCE AND EXPECTATIONS
Decisions subject to regulatory oversight that are made by Insurers using AI Systems
must comply with the legal and regulatory standards that apply to those decisions, including
unfair trade practice laws. These standards require, at a minimum, that decisions made by
Insurers are not inaccurate, arbitrary, capricious, or unfairly discriminatory. Compliance with
these standards is required regardless of the tools and methods Insurers use to make such
decisions. However, because, in the absence of proper controls, AI has the potential to increase
the risk of inaccurate, arbitrary, capricious, or unfairly discriminatory outcomes for consumers,
it is important that Insurers adopt and implement controls specifically related to their use of AI
that are designed to mitigate the risk of Adverse Consumer Outcomes.
Consistent therewith, all Insurers authorized to do business in this state are expected to
develop, implement, and maintain a written program (an “AIS Program”) for the responsible use
of AI Systems that make, or support decisions related to regulated insurance practices. The AIS
Program should be designed to mitigate the risk of Adverse Consumer Outcomes, including, at
a minimum, the statutory provisions set forth in Section 1 of this bulletin.
The Department recognizes that robust governance, risk management controls, and
internal audit functions play a core role in mitigating the risk that decisions driven by AI Systems
will violate unfair trade practice laws and other applicable existing legal standards. The
Department also encourages the development and use of verification and testing methods to
identify errors and bias in Predictive Models and AI Systems, as well as the potential for unfair
discrimination in the decisions and outcomes resulting from the use of Predictive Models and AI
Systems.
Page 5 of 11
The controls and processes that an Insurer adopts and implements as part of its AIS
Program should be reflective of, and commensurate with, the Insurer’s own assessment of the
degree and nature of risk posed to consumers by the AI Systems that it uses, considering: (i) the
nature of the decisions being made, informed, or supported using the AI System; (ii) the type
and Degree of Potential Harm to Consumers resulting from the use of AI Systems; (iii) the extent
to which humans are involved in the final decision-making process; (iv) the transparency and
explainability of outcomes to the impacted consumer; and (v) the extent and scope of the
insurer’s use or reliance on data, Predictive Models, and AI Systems from third parties.
Similarly, controls and processes should be commensurate with both the risk of Adverse
Consumer Outcomes and the Degree of Potential Harm to Consumers.
As discussed in Section 4, the decisions made as a result of an Insurer’s use of AI
Systems are subject to the Department’s examination to determine that the reliance on AI
Systems are compliant with all applicable existing legal standards governing the conduct of the
Insurer.
AIS Program Guidelines
1.0
General Guidelines
1.1
The AIS Program should be designed to mitigate the risk that the Insurer’s use of
an AI System will result in Adverse Consumer Outcomes.
1.2
The AIS Program should address governance, risk management controls, and
internal audit functions.
1.3
The AIS Program should vest responsibility for the development,
implementation, monitoring, and oversight of the AIS Program and for setting the Insurer’s
strategy for AI Systems with senior management accountable to the board or an appropriate
committee of the board.
1.4
The AIS Program should be tailored to and proportionate with the Insurer’s use
and reliance on AI and AI Systems. Controls and procedures should be focused on the mitigation
of Adverse Consumer Outcomes and the scope of the controls and procedures applicable to a
given AI System use case should reflect and align with the Degree of Potential Harm to
Consumers with respect to that use case.
1.5
The AIS Program may be independent of or part of the Insurer’s existing
Enterprise Risk Management (ERM) program. The AIS Program may adopt, incorporate, or rely
upon, in whole or in part, a framework or standards developed by an official third-party standard
organization, such as the National Institute of Standards and Technology (NIST) Artificial
Intelligence Risk Management Framework, Version 1.0.
1.6
The AIS Program should address the use of AI Systems across the insurance life
cycle, including areas such as product development and design, marketing, use, underwriting,
rating and pricing, case management, claim administration and payment, and fraud detection.
Page 6 of 11
1.7
The AIS Program should address all phases of an AI System’s life cycle,
including design, development, validation, implementation (both systems and business), use, ongoing monitoring, updating and retirement.
1.8
The AIS Program should address the AI Systems used with respect to regulated
insurance practices whether developed by the Insurer or a third-party vendor.
1.9
The AIS Program should include processes and procedures providing notice to
impacted consumers that AI Systems are in use and provide access to appropriate levels of
information based on the phase of the insurance life cycle in which the AI Systems are being
used.
2.0
Governance
The AIS Program should include a governance framework for the oversight of AI Systems
used by the Insurer. Governance should prioritize transparency, fairness, and accountability in the
design and implementation of the AI Systems, recognizing that proprietary and trade secret
information must be protected. An Insurer may consider adopting new internal governance
structures or rely on the Insurer’s existing governance structures; however, in developing its
governance framework, the Insurer should consider addressing the following items:
2.1
The policies, processes, and procedures, including risk management and internal
controls, to be followed at each stage of an AI System life cycle, from proposed development to
retirement.
2.2
The requirements adopted by the Insurer to document compliance with the AIS
Program policies, processes, procedures, and standards. Documentation requirements should be
developed with Section 4 in mind.
2.3
The Insurer’s internal AI System governance accountability structure, such as:
a)
The formation of centralized, federated, or otherwise constituted
committees comprised of representatives from appropriate disciplines and
units within the Insurer, such as business units, product specialists,
actuarial, data science and analytics, underwriting, claims, compliance,
and legal.
b)
Scope of responsibility and authority, chains of command, and decisional
hierarchies.
c)
The independence of decision-makers and lines of defense at successive
stages of the AI System life cycle.
d)
Monitoring, auditing, escalation, and reporting protocols and requirements.
Page 7 of 11
e)
Development and implementation of ongoing training and supervision of
personnel.
2.4
Specifically with respect to Predictive Models: the Insurer’s processes and
procedures for designing, developing, verifying, deploying, using, updating, and monitoring
Predictive Models, including a description of methods used to detect and address errors,
performance issues, outliers, or unfair discrimination in the insurance practices resulting from the
use of the Predictive Model.
3.0
Risk Management and Internal Controls
The AIS Program should document the Insurer’s risk identification, mitigation, and
management framework and internal controls for AI Systems generally and at each stage of the
AI System life cycle. Risk management and internal controls should address the following items:
3.1
The oversight and approval process for the development, adoption, or acquisition
of AI Systems, as well as the identification of constraints and controls on automation and design
to align and balance function with risk.
3.2
Data practices and accountability procedures, including data currency, lineage,
quality, integrity, bias analysis and minimization, and suitability.
3.3
Management and oversight of Predictive Models (including algorithms used
therein), including:
a)
Inventories and descriptions of the Predictive Models.
b)
Detailed documentation of the development and use of the Predictive
Models.
c)
Assessments such as interpretability, repeatability, robustness, regular
tuning, reproducibility, traceability, model drift, and the auditability of
these measurements where appropriate.
3.4
Validating, testing, and retesting as necessary to assess the generalization of AI
System outputs upon implementation, including the suitability of the data used to develop, train,
validate and audit the model. Validation can take the form of comparing model performance on
unseen data available at the time of model development to the performance observed on data postimplementation, measuring performance against expert review, or other methods.
3.5
The protection of non-public information, particularly consumer information,
including unauthorized access to the Predictive Models themselves.
3.6
Data and record retention.
3.7
Specifically with respect to Predictive Models: a narrative description of the
model’s intended goals and objectives and how the model is developed and validated to ensure
Page 8 of 11
that the AI Systems that rely on such models correctly and efficiently predict or implement those
goals and objectives.
4.0
Third-Party AI Systems and Data
Each AIS Program should address the Insurer’s process for acquiring, using, or relying
on (i) third-party data to develop AI Systems; and (ii) AI Systems developed by a third party,
which may include, as appropriate, the establishment of standards, policies, procedures, and
protocols relating to the following considerations:
4.1
Due diligence and the methods employed by the Insurer to assess the third party
and its data or AI Systems acquired from the third party to ensure that decisions made or
supported from such AI Systems that could lead to Adverse Consumer Outcomes will meet the
legal standards imposed on the Insurer itself.
4.2
Where appropriate and available, the inclusion of terms in contracts with third
parties that:
a)
Provide audit rights and/or entitle the Insurer to receive audit reports by
qualified auditing entities.
b)
Require the third party to cooperate with the Insurer with regard to regulatory
inquiries and investigations related to the Insurer’s use of the third-party’s
product or services.
4.3
The performance of contractual rights regarding audits and/or other activities
to confirm the third-party’s compliance with contractual and, where applicable, regulatory
requirements.
SECTION 4: REGULATORY OVERSIGHT AND EXAMINATION CONSIDERATIONS
The Department’s regulatory oversight of Insurers includes oversight of an Insurer’s
conduct in the state, including its use of AI Systems to make or support decisions that impact
consumers. Regardless of the existence or scope of a written AIS Program, in the context of an
investigation or market conduct action, an Insurer can expect to be asked about its development,
deployment, and use of AI Systems, or any specific Predictive Model, AI System or application
and its outcomes (including Adverse Consumer Outcomes) from the use of those AI Systems, as
well as any other information or documentation deemed relevant by the Department.
Insurers should expect those inquiries to include (but not be limited to) the Insurer’s
governance framework, risk management, and internal controls (including the considerations
identified in Section 3). In addition to conducting a review of any of the items listed in this
Bulletin, a regulator may also ask questions regarding any specific model, AI System, or its
application, including requests for the following types of information and/or documentation:
Page 9 of 11
1.
Information and Documentation Relating to AI System Governance, Risk
Management, and Use Protocols
1.1.
Information and documentation related to or evidencing the Insurer’s AIS Program,
including:
a)
The written AIS Program.
b)
Information and documentation relating to or evidencing the adoption of the
AIS Program.
c)
The scope of the Insurer’s AIS Program, including any AI Systems and
technologies not included in or addressed by the AIS Program.
d)
How the AIS Program is tailored to and proportionate with the Insurer’s
use and reliance on AI Systems, the risk of Adverse Consumer Outcomes,
and the Degree of Potential Harm to Consumers.
e)
The policies, procedures, guidance, training materials, and other
information relating to the adoption, implementation, maintenance,
monitoring, and oversight of the Insurer’s AIS Program, including:
i.
Processes and procedures for the development, adoption, or
acquisition of AI Systems, such as:
(1)
Identification of constraints and controls on
automation and design.
(2)
Data governance and controls, any practices related to data
lineage, quality, integrity, bias analysis and minimization,
suitability, and Data Currency.
ii.
Processes and procedures related to the management and oversight
of Predictive Models, including measurements, standards, or
thresholds adopted or used by the Insurer in the development,
validation, and oversight of models and AI Systems.
iii.
Protection of non-public information, particularly consumer
information, including unauthorized access to Predictive Models
themselves.
1.2.
Information and documentation relating to the Insurer’s pre-acquisition/pre-use
diligence, monitoring, oversight, and auditing of data or AI Systems developed by a third party.
1.3.
Information and documentation relating to or evidencing the Insurer’s
implementation and compliance with its AIS Program, including documents relating to the
Insurer’s monitoring and audit activities respecting compliance, such as:
Page 10 of 11
a)
Documentation relating to or evidencing the formation and ongoing
operation of the Insurer’s coordinating bodies for the development, use,
and oversight of AI Systems.
b)
Documentation related to data practices and accountability procedures,
including data lineage, quality, integrity, bias analysis and minimization,
suitability, and Data Currency.
c)
Management and oversight of Predictive Models and AI
Systems, including:
i.
The Insurer’s inventories and descriptions of Predictive Models,
and AI Systems used by the Insurer to make or support decisions
that can result in Adverse Consumer Outcomes.
ii.
As to any specific Predictive Model or AI System that is the subject
of investigation or examination:
(1)
Documentation of compliance with all applicable AI
Program policies, protocols, and procedures in the
development, use, and oversight of Predictive Models and
AI Systems deployed by the Insurer.
(2)
Information about data used in the development and
oversight of the specific model or AI System, including the
data source, provenance, data lineage, quality, integrity,
bias analysis and minimization, suitability, and Data
Currency.
(3)
Information related to the techniques, measurements,
thresholds, and similar controls used by the Insurer.
d)
Documentation related to validation, testing, and auditing, including
evaluation of Model Drift to assess the reliability of outputs that influence
the decisions made based on Predictive Models. Note that the nature of
validation, testing, and auditing should be reflective of the underlying
components of the AI System, whether based on Predictive Models or
Generative AI.
2.
Third-Party AI Systems and Data
In addition, if the investigation or examination concerns data, Predictive Models, or AI
Systems collected or developed in whole or in part by third parties, the Insurer should also expect
the Department to request the following additional types of information and documentation.
Page 11 of 11
2.1
Due diligence conducted on third parties and their data, models, or AI Systems.
2.2
Contracts with third-party AI System, model, or data vendors, including terms
relating to representations, warranties, data security and privacy, data sourcing,
intellectual property rights, confidentiality and disclosures, and/or cooperation
with regulators.
2.3
Audits and/or confirmation processes performed regarding third-party compliance
with contractual and, where applicable, regulatory obligations.
2.4
Documentation pertaining to validation, testing, and auditing, including evaluation
of Model Drift.
The Department recognizes that Insurers may demonstrate their compliance with the laws
that regulate their conduct in the state in their use of AI Systems through alternative means,
including through practices that differ from those described in this bulletin. The goal of the
bulletin is not to prescribe specific practices or to prescribe specific documentation requirements.
Rather, the goal is to ensure that Insurers in the state are aware of the Department’s expectations
as to how AI Systems will be governed and managed and of the kinds of information and
documents about an Insurer’s AI Systems that the department expects an Insurer to produce when
requested.
As in all cases, investigations and market conduct actions may be performed using
procedures that vary in nature, extent, and timing in accordance with regulatory judgment. Work
performed may include inquiry, examination of company documentation, or any of the continuum
of market actions described in the NAIC’s Market Regulation Handbook. These activities may
involve the use of contracted specialists with relevant subject matter expertise. Nothing in this
bulletin limits the authority of the Department to conduct any regulatory investigation,
examination, or enforcement action relative to any act or omission of any Insurer that the
Department is authorized to perform.
Questions concerning this bulletin should be directed to the Oklahoma
Insurance Department by email to marketregulation@agency.ok.gov.